|
Vakkalanka, R K; Woo, C; Kirou, K A et al. (1999) Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera. Arthritis Rheum 42:871-81
|
|
Mevorach, D; Mascarenhas, J O; Gershov, D et al. (1998) Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med 188:2313-20
|
|
Mevorach, D; Zhou, J L; Song, X et al. (1998) Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 188:387-92
|
|
Schattner, E J; Mascarenhas, J; Reyfman, I et al. (1998) Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type costimulatory capacity. Blood 91:2689-97
|
|
Bishop, J Y; Schattner, E J; Friedman, S M (1998) CD40 ligation impedes lymphoblastoid B cell proliferation and S-phase entry. Leuk Res 22:319-27
|
|
Sammaritano, L R; Ng, S; Sobel, R et al. (1997) Anticardiolipin IgG subclasses: association of IgG2 with arterial and/or venous thrombosis. Arthritis Rheum 40:1998-2006
|
|
Bullard, D C; King, P D; Hicks, M J et al. (1997) Intercellular adhesion molecule-1 deficiency protects MRL/MpJ-Fas(lpr) mice from early lethality. J Immunol 159:2058-67
|
|
Vaishnaw, A K; McNally, J D; Elkon, K B (1997) Apoptosis in the rheumatic diseases. Arthritis Rheum 40:1917-27
|
|
Georgescu, L; Vakkalanka, R K; Elkon, K B et al. (1997) Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand. J Clin Invest 100:2622-33
|
|
McNally, J; Yoo, D H; Drappa, J et al. (1997) Fas ligand expression and function in systemic lupus erythematosus. J Immunol 159:4628-36
|
Showing the most recent 10 out of 24 publications
